UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 24, 2016

  

 

MEDIVATION, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32836   13-3863260

(State or other jurisdiction

of incorporation)

 

(Commission

File No.)

 

(IRS Employer

Identification No.)

525 Market Street, 36 th Floor

San Francisco, California 94105

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (415) 543-3470

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 8.01 Other Events.

On June 24, 2016, Medivation, Inc. (the “Company”) issued a press release announcing that Glass, Lewis & Co., LLC recommends that the Company’s stockholders support the Company’s board of directors by rejecting Sanofi’s solicitation efforts (the “Glass Lewis Recommendation”). A copy of the press release is attached hereto as Exhibit 99.1.

On June 24, 2016, the Company sent a letter to its employees addressing the Glass Lewis Recommendation. A copy of the letter to the Company’s employees is attached hereto as Exhibit 99.2.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

99.1    Press release of Medivation, Inc. dated June 24, 2016.
99.2    Letter to Medivation employees sent on June 24, 2016.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    MEDIVATION, INC.
Dated: June 24, 2016     By:  

/s/ Andrew Powell

      Andrew Powell
      General Counsel


EXHIBIT INDEX

 

99.1    Press release of Medivation, Inc. dated June 24, 2016.
99.2    Letter to Medivation employees sent on June 24, 2016.
Medivation, Inc. (MM) (NASDAQ:MDVN)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Medivation, Inc. (MM) Charts.
Medivation, Inc. (MM) (NASDAQ:MDVN)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Medivation, Inc. (MM) Charts.